Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Isaacs-Bernal

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
ACS Biomaterials Science & Engineering|March 6, 2026
A Customizable Antibody Delivery Strategy Using Fc-Affinity LigandsDaniela Isaacs-Bernal, Noor E Bahsoun, Lia Huo, et al.
Biomaterials|January 14, 2026
Tuning hydrogel affinity to control the release of antibodiesDaniela Isaacs-Bernal, Brenda Coles, Lia Huo, et al.
Nanoscale Advances|June 16, 2025
RNA lipid nanoparticles stabilized during nebulization through excipient selectionKai V Slaughter, Daniela Isaacs-Bernal, Eric N Donders, et al.
Ophthalmology Science|October 10, 2022
Topical Nanoemulsion of a Runt-related Transcription Factor 1 Inhibitor for the Treatment of Pathologic Ocular AngiogenesisSantiago Delgado-Tirado, Lucia Gonzalez-Buendia, Miranda An, et al.
Scientific Reports|December 1, 2020
Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathySantiago Delgado-Tirado, Dhanesh Amarnani, Guannan Zhao, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
ACS Biomaterials Science & Engineering|March 6, 2026
A Customizable Antibody Delivery Strategy Using Fc-Affinity LigandsDaniela Isaacs-Bernal, Noor E Bahsoun, Lia Huo, et al.
Biomaterials|January 14, 2026
Tuning hydrogel affinity to control the release of antibodiesDaniela Isaacs-Bernal, Brenda Coles, Lia Huo, et al.
Nanoscale Advances|June 16, 2025
RNA lipid nanoparticles stabilized during nebulization through excipient selectionKai V Slaughter, Daniela Isaacs-Bernal, Eric N Donders, et al.
Ophthalmology Science|October 10, 2022
Topical Nanoemulsion of a Runt-related Transcription Factor 1 Inhibitor for the Treatment of Pathologic Ocular AngiogenesisSantiago Delgado-Tirado, Lucia Gonzalez-Buendia, Miranda An, et al.
Scientific Reports|December 1, 2020
Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathySantiago Delgado-Tirado, Dhanesh Amarnani, Guannan Zhao, et al.
Pageof 1